Your browser doesn't support javascript.
loading
Immunomodulation for maxillofacial reconstructive surgery / 대한악안면성형재건외과학회지
Maxillofacial Plastic and Reconstructive Surgery ; : 5-2020.
Article | WPRIM | ID: wpr-836939
ABSTRACT
Immunomodulation is a technique for the modulation of immune responses against graft material to improve surgical success rates. The main target cell for the immunomodulation is a macrophage because it is the reaction site of the graft and controls the healing process. Macrophages can be classified into M1 and M2 types. Most immunomodulation techniques focus on the rapid differentiation of M2-type macrophage. An M2 inducer, 4-hexylresorcinol, has been recently identified and is used for bone grafts and dental implant coatings.
Full text: Available Index: WPRIM (Western Pacific) Journal: Maxillofacial Plastic and Reconstructive Surgery Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Journal: Maxillofacial Plastic and Reconstructive Surgery Year: 2020 Type: Article